Groundbreaking mRNA vaccine administered to captive elephant to fight EEHV

FHS
July 13, 2024
4:38 am

Colossal, the de-extinction company, announces that the mRNA vaccine it helped to provide research support and acceleration funding for has been administered to the first elephant in captivity.

The politics behind drug shortages: Senators talk issues with generics market, CMS payments

The generic drug market took center stage Tuesday at a Senate Finance Committee hearing on drug shortages as lawmakers on Capitol Hill work to remedy

December 6, 2023

Lancet Menopause Series Wants to Change How Society Views ‘The Change’

Researchers warned against the “over-medicalization” of menopause in a four-paper series in The Lancet, and argued for a fresh approach that goes beyond the treatment

March 6, 2024

Pristimerin induces apoptosis in non-small cell lung cancer by targeting thioredoxin reductase

Announcing a new publication for Acta Materia Medica journal. Elevated cellular oxidative stress is a common marker of cancer cell dysregulation caused by malignant transformation.

July 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.